J Kuch

3.4k total citations
24 papers, 1.3k citations indexed

About

J Kuch is a scholar working on Cardiology and Cardiovascular Medicine, Pathology and Forensic Medicine and Rheumatology. According to data from OpenAlex, J Kuch has authored 24 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cardiology and Cardiovascular Medicine, 4 papers in Pathology and Forensic Medicine and 4 papers in Rheumatology. Recurrent topics in J Kuch's work include Cardiac pacing and defibrillation studies (5 papers), Cardiovascular Function and Risk Factors (5 papers) and Heart Failure Treatment and Management (5 papers). J Kuch is often cited by papers focused on Cardiac pacing and defibrillation studies (5 papers), Cardiovascular Function and Risk Factors (5 papers) and Heart Failure Treatment and Management (5 papers). J Kuch collaborates with scholars based in Poland, United States and Canada. J Kuch's co-authors include Salim Yusuf, Whedy Wang, John O. Parker, Carl J. Pepine, Sandra Skettino, Bernard Chaitman, David Hébert, Peter C. Hanley, Jeanenne J. Nelson and Andrew A. Wolff and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and European Heart Journal.

In The Last Decade

J Kuch

21 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J Kuch Poland 9 1.1k 201 158 138 114 24 1.3k
P A Majid Netherlands 19 679 0.6× 185 0.9× 88 0.6× 93 0.7× 104 0.9× 33 1.0k
J Kjekshus Spain 7 1.2k 1.1× 161 0.8× 81 0.5× 146 1.1× 104 0.9× 10 1.4k
W S Hillis United Kingdom 19 534 0.5× 84 0.4× 107 0.7× 50 0.4× 100 0.9× 55 971
Christopher Chew United States 14 717 0.7× 171 0.9× 175 1.1× 26 0.2× 116 1.0× 22 998
R Canepa‐Anson United Kingdom 17 919 0.9× 171 0.9× 78 0.5× 86 0.6× 202 1.8× 41 1.1k
Toshikazu Goto Japan 14 692 0.6× 462 2.3× 142 0.9× 109 0.8× 90 0.8× 54 1.1k
John E. Strobeck United States 18 1.3k 1.2× 211 1.0× 309 2.0× 78 0.6× 87 0.8× 44 1.7k
N Pauly United Kingdom 8 1.3k 1.3× 122 0.6× 69 0.4× 272 2.0× 157 1.4× 16 1.5k
Antone F. Salel United States 18 648 0.6× 318 1.6× 80 0.5× 124 0.9× 70 0.6× 54 1.1k
William E. Harston United States 8 1.7k 1.6× 110 0.5× 121 0.8× 118 0.9× 170 1.5× 11 1.9k

Countries citing papers authored by J Kuch

Since Specialization
Citations

This map shows the geographic impact of J Kuch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Kuch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Kuch more than expected).

Fields of papers citing papers by J Kuch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Kuch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Kuch. The network helps show where J Kuch may publish in the future.

Co-authorship network of co-authors of J Kuch

This figure shows the co-authorship network connecting the top 25 collaborators of J Kuch. A scholar is included among the top collaborators of J Kuch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Kuch. J Kuch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kuch, J, et al.. (2006). Polish thread in the history of circulatory physiology.. PubMed. 57 Suppl 1. 5–41. 5 indexed citations
2.
Young, James B., Mark E. Dunlap, Marc A. Pfeffer, et al.. (2004). Mortality and Morbidity Reduction With Candesartan in Patients With Chronic Heart Failure and Left Ventricular Systolic Dysfunction. Circulation. 110(17). 2618–2626. 282 indexed citations
3.
Chaitman, Bernard, Sandra Skettino, John O. Parker, et al.. (2004). Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina. Journal of the American College of Cardiology. 43(8). 1375–1382. 410 indexed citations
4.
Braksator, Wojciech, et al.. (2004). [Factors influencing cardiac complications in patients with type-2 diabetes mellitus and silent myocardial ischaemia: five-year follow-up].. PubMed. 112(6). 1433–43. 6 indexed citations
5.
Chaitman, Bernard, Sandra Skettino, Carl J. Pepine, et al.. (2003). Ranolazine increases exercise performance and decreases hemoglobin A1C in angina patients with diabetes. Journal of the American College of Cardiology. 41(6). 378–378. 5 indexed citations
6.
Stępińska, Janina, Zygmunt Sadowski, Marek Banaszewski, et al.. (2002). Calcium blocker therapy before myocardial infarction increases post-infarction short- and long-term mortality. Data from the INJECT trial.. PubMed. 57(12). 512–9. 1 indexed citations
7.
Wikstrand, John, Å. Hjalmarson, Finn Waagstein, et al.. (2001). Achieved metoprolol CR/XL dose and clinical outcomes Analysis of the experience in MERIT-HF. 75323. 3 indexed citations
8.
Granger, Christopher B., Georg Ertl, J Kuch, et al.. (2000). Randomized trial of candesartan cilexetil in the treatment of patients with congestive heart failure and a history of intolerance to angiotensin-converting enzyme inhibitors. American Heart Journal. 139(4). 609–617. 97 indexed citations
9.
Bart, Bradley A., Georg Ertl, Peter Held, et al.. (1999). Contemporary management of patients with left ventricular systolic dysfunction. Results from the Study of Patients Intolerant of Converting Enzyme Inhibitors (SPICE) Registry. European Heart Journal. 20(16). 1182–1190. 81 indexed citations
10.
Sadowski, Zygmunt, John H. Alexander, A Dyduszyński, et al.. (1999). Multicenter randomized trial and a systematic overview of lidocaine in acute myocardial infarction. American Heart Journal. 137(5). 792–798. 45 indexed citations
11.
Budaj, Andrzej, J Kuch, Maria Krzemińska‐Pakuła, et al.. (1996). Lack of effect of amiodarone on survival after extensive infarction. Coronary Artery Disease. 7(4). 315–320. 9 indexed citations
12.
Ceremuźyński, L, Andrzej Budaj, J Kuch, et al.. (1995). 1023-114 Long-term Secondary Prevention After Myocardial Infarction with Amiodarone. Journal of the American College of Cardiology. 25(2). 403A–403A.
13.
Kuch, J, et al.. (1993). [Localization of myocardial infarction with the help of EKG and two-dimensional echocardiography. Controversies].. PubMed. 38(1). 21–5. 1 indexed citations
14.
Kuch, J, et al.. (1992). [Aneurysms in acute myocardial infarction (multicenter studies)].. PubMed. 37(11). 307–10.
15.
Ceremuźyński, L, Maria Krzemińska‐Pakuła, J Kuch, et al.. (1992). Effect of amiodarone on mortality after myocardial infarction: A double-blind, placebo-controlled, pilot study. Journal of the American College of Cardiology. 20(5). 1056–1062. 232 indexed citations
16.
Kuch, J. (1973). Autoantibodies directed against heart antigens and endocrine reactivity in patients with recent myocardial infarction. Cardiovascular Research. 7(5). 649–654. 13 indexed citations
17.
Walz, D. T., et al.. (1971). Adjuvant-Induced Arthritis in Rats I. Temporal Relationship of Physiological, Biochemical, and Hematological Parameters. Experimental Biology and Medicine. 136(3). 907–910. 35 indexed citations
18.
Chorzelski, Tadeusz P. & J Kuch. (1969). Atypical myocardial infarction in a case of pemphigus in the light of immunofluorescence studies.. PubMed. 4(6). 691–5. 4 indexed citations
19.
Chorzelski, T & J Kuch. (1968). [Anticardiac antibodies and "pemphigus" autoantibodies in a patient with pemphigus and myocardial infarction].. PubMed. 41(6). 825–30. 3 indexed citations
20.
Kuch, J & Tadeusz P. Chorzelski. (1968). [Immunofluorescence studies in recent myocardial infarction].. PubMed. 41(6). 729–37. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P A Majid Breakdown of academic impact, for papers by J Kjekshus Breakdown of academic impact, for papers by W S Hillis Breakdown of academic impact, for papers by Christopher Chew Breakdown of academic impact, for papers by R Canepa‐Anson Breakdown of academic impact, for papers by Toshikazu Goto Breakdown of academic impact, for papers by John E. Strobeck Breakdown of academic impact, for papers by N Pauly Breakdown of academic impact, for papers by Antone F. Salel Breakdown of academic impact, for papers by William E. Harston
Rankless by CCL
2026